BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effects of extracted oil of fermented Tartary buckwheat on lipid-lowering, inflammation modulation, and gut microbial regulation in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 14 Issue 24 Pages: 10814-10828 Pub: 2023 Dec 11 Epub: 2023 Dec 11 Authors Yang X , Zhu A , Li X , He S , Zhu Y , Anyan W , Qin L , Zeng H , |
|
|
Probiotic-fermented rice buckwheat alleviates high-fat diet-induced hyperlipidemia in mice by suppressing lipid accumulation and modulating gut microbiota. ✅
Go to Publication ✅
Food research international (Ottawa, Ont.) (Food Res Int ) Vol: 155 Issue Pages: 111125 Pub: 2022 May Epub: 2022 Mar 12 Authors Yan J , Xue Q , Chen W , Wang K , Peng D , Jiang J , Li P , Du B , |
|
|
Probiotic-fermented black tartary buckwheat alleviates hyperlipidemia and gut microbiota dysbiosis in rats fed with a high-fat diet. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 12 Issue 13 Pages: 6045-6057 Pub: 2021 Jul 5 Epub: Authors Ren Y , Wu S , Xia Y , Huang J , Ye J , Xuan Z , Li P , Du B , |
|
|
Regulation of tartary buckwheat-resistant starch on intestinal microflora in mice fed with high-fat diet. ✅
Go to Publication ✅
Food science & nutrition (Food Sci Nutr ) Vol: 8 Issue 7 Pages: 3243-3251 Pub: 2020 Jul Epub: 2020 May 12 Authors Zhou Y , Wei Y , Yan B , Zhao S , Zhou X , |
|
|
Regulation of tartary buckwheat-resistant starch on intestinal microflora in mice fed with high-fat diet. ✅
Go to Publication ✅
Food science & nutrition (Food Sci Nutr ) Vol: 8 Issue 7 Pages: 3243-3251 Pub: 2020 Jul Epub: 2020 May 12 Authors Zhou Y , Wei Y , Yan B , Zhao S , Zhou X , |
|
|
Fagopyrum esculentum polysaccharides mitigate obesity by reshaping gut microbiota and enhancing lipid metabolism in high-fat diet-fed mice. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 322 Issue Pt 1 Pages: 146668 Pub: 2025 Aug 6 Epub: 2025 Aug 6 Authors Fang CY , Chen SY , Liao CC , Chen JD , Yen GC , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
